Pan-Asia Index Rebalances/ Events/ Delta One, Periscope Analytics

Brian Freitas

Highly experienced ex-Delta One trader with 17 years of experience trading arbitrage and related strategies across Asian markets.

Exempt Financial Adviser (EFA) under CrossASEAN Research Pte Ltd.

It is important to note that the information provided by Periscope Analytics is based on publicly available data and own knowledge, which has been gathered and synthesized from a variety of sources. While every effort has been made to ensure the accuracy and completeness of the information provided, it is not guaranteed to be free from errors or omissions.

All forecasts and estimates are based on information that has been obtained from public sources that are considered to be reliable. The sources include, but are not limited to, company announcements, exchange filings, ETF and other passive investment vehicle holdings, and free float and volume data from third-party data providers. Periscope Analytics does not guarantee the accuracy and completeness of the forecasts, estimates and/or other information.

Pan-Asia Index Rebalances/ Events/ Delta One

King Slide Works (2059 TT): Sliding into a Global Index

Taiwan Top 50 ETF Rebalance Preview: Another Inclusion for King Slide

Taiwan Top 50 ETF Rebalance Preview: Hat Trick for Caliway Biopharma?

Periscope Analytics

Periscope Analytics focuses on event-driven trades across Asia Pacific and provides comprehensive, timely and systematic coverage of index changes to major Asia Pacific indices in a structured manner.

The analysis includes forecasted inclusions and exclusions to all major Asian indices that have significant amount of tracking assets, including estimates of passive buy/sell flow on the stocks. The service also provides commentary and impact of market consultations, ground rule changes, and other events (IPOs, spin-offs, M&A) that could lead to index changes and passive flow.

Periscope Analytics works with multi-strategy hedge funds, proprietary trading firms, stat arb trading groups and long-only investors that invest and trade in the Asia Pacific region with the data being used to trade index rebalances, avoid pre-positioning and passive flow, and to time entry into and exit from stocks.

Event-Driven Trades Across Asia Pacific

Index Rebalance

Caliway Biopharmaceuticals / Index Rebalance

<ul>
<li>
<a href="https://www.smartkarma.com/entities/caliway-biopharmaceuticals-co-ltd" target="_blank" data-smartkarma-citation="entities:44038:1" rel="noopener">Caliway Biopharmaceuticals (6919 TT)</a> and <a href="https://www.smartkarma.com/entities/king-slide-works-co-ltd" target="_blank" data-smartkarma-citation="entities:7130:1" rel="noopener">King Slide Works (2059 TT)</a> replace <a href="https://www.smartkarma.com/entities/taiwan-cement" target="_blank" data-smartkarma-citation="entities:19736:1" rel="noopener">Taiwan Cement (1101 TT)</a> and <a href="https://www.smartkarma.com/entities/pharmaessentia-corp" target="_blank" data-smartkarma-citation="entities:16461:1" rel="noopener">Pharmaessentia Corp (6446 TT)</a> in the Yuanta/P-Shares Taiwan Top 50 ETF in September.</li>
<li>
<a href="https://www.smartkarma.com/entities/caliway-biopharmaceuticals-co-ltd" target="_blank" data-smartkarma-citation="entities:44038:1" rel="noopener">Caliway Biopharmaceuticals (6919 TT)</a> and <a href="https://www.smartkarma.com/entities/king-slide-works-co-ltd" target="_blank" data-smartkarma-citation="entities:7130:1" rel="noopener">King Slide Works (2059 TT)</a> were added to a global index in August and that resulted in a large percentage of float being bought.</li>
<li>
<a href="https://www.smartkarma.com/entities/caliway-biopharmaceuticals-co-ltd" target="_blank" data-smartkarma-citation="entities:44038:1" rel="noopener">Caliway Biopharmaceuticals (6919 TT)</a> will be added to another global index in September and that will further reduce the real float of the stock.</li>
</ul>



Caliway Biopharmaceuticals (6919 TT) and King Slide Works (2059 TT) replace Taiwan Cement (1101 TT) and Pharmaessentia Corp (6446 TT) in the Yuanta/P-Shares Taiwan Top 50 ETF in September.

Caliway Biopharmaceuticals (6919 TT) and King Slide Works (2059 TT) were added to a global index in August and that resulted in a large percentage of float being bought.

Caliway Biopharmaceuticals (6919 TT) will be added to another global index in September and that will further reduce the real float of the stock.


Taiwan Top 50 ETF Rebalance: Another Inclusion for Caliway Biopharma & King Slide